HomeCompareLBTSF vs GBDC

LBTSF vs GBDC: Dividend Comparison 2026

LBTSF yields 1.34% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $7.96M in total portfolio value
10 years
LBTSF
LBTSF
● Live price
1.34%
Share price
$15.35
Annual div
$0.21
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.89M
Annual income
$11,275,798.89
Full LBTSF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — LBTSF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBTSFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBTSF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBTSF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBTSF
Annual income on $10K today (after 15% tax)
$114.07/yr
After 10yr DRIP, annual income (after tax)
$9,584,429.06/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $4,398,694.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBTSF + GBDC for your $10,000?

LBTSF: 50%GBDC: 50%
100% GBDC50/50100% LBTSF
Portfolio after 10yr
$16.87M
Annual income
$13,863,266.36/yr
Blended yield
82.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

LBTSF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.0
Piotroski
7/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBTSF buys
0
GBDC buys
0
No recent congressional trades found for LBTSF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBTSFGBDC
Forward yield1.34%11.86%
Annual dividend / share$0.21$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$12.89M$20.85M
Annual income after 10y$11,275,798.89$16,450,733.83
Total dividends collected$12.74M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: LBTSF vs GBDC ($10,000, DRIP)

YearLBTSF PortfolioLBTSF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,968$268.40$12,492$1,791.70$1.5KGBDC
2$12,286$550.27$16,527$3,160.58$4.2KGBDC
3$14,299$1,152.15$23,588$5,904.90$9.3KGBDC
4$17,806$2,506.24$37,141$11,901.65$19.3KGBDC
5$24,886$5,833.59$66,205$26,463.38$41.3KGBDC
6$41,867$15,239.53$137,452$66,612.65$95.6KGBDC
7$92,721$47,922.73$342,372$195,298.53$249.7KGBDC
8$297,587$198,376.17$1,053,292$686,954.33$755.7KGBDC
9$1,508,490$1,190,071.76$4,111,439$2,984,416.95$2.60MGBDC
10$12,889,884$11,275,798.89$20,849,974$16,450,733.83$7.96MGBDC

LBTSF vs GBDC: Complete Analysis 2026

LBTSFStock

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Full LBTSF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this LBTSF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBTSF vs SCHDLBTSF vs JEPILBTSF vs OLBTSF vs KOLBTSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.